AWH Aspira Women's Health Inc

Price (delayed)

$5.99

Market cap

$669.18M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.18

Enterprise value

$657.67M

Sector: Healthcare
Industry: Diagnostics & Research

Highlights

Aspira Women's Health's revenue has increased by 3.1% from the previous quarter and by 2.5% YoY
The company's equity fell by 33% QoQ but it rose by 11% YoY
AWH's gross profit is down by 19% since the previous quarter but it is up by 3.4% year-on-year
The debt has surged by 98% since the previous quarter
The company's quick ratio fell by 36% QoQ and by 14% YoY

Key stats

What are the main financial stats of AWH
Market
Shares outstanding
111.72M
Market cap
$669.18M
Enterprise value
$657.67M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
64.15
Price to sales (P/S)
129.72
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
141.4
Earnings
Revenue
$4.65M
EBIT
-$17.91M
EBITDA
-$17.61M
Free cash flow
-$15.22M
Per share
EPS
-$0.18
Free cash flow per share
-$0.15
Book value per share
$0.09
Revenue per share
$0.05
TBVPS
$0.19
Balance sheet
Total assets
$19.61M
Total liabilities
$9.89M
Debt
$5.12M
Equity
$9.72M
Working capital
$12.2M
Liquidity
Debt to equity
0.53
Current ratio
2.91
Quick ratio
2.73
Net debt/EBITDA
0.65
Margins
EBITDA margin
-378.7%
Gross margin
26.6%
Net margin
-385%
Operating margin
-386.6%
Efficiency
Return on assets
-111.4%
Return on equity
-194.4%
Return on invested capital
-4,137.5%
Return on capital employed
-135.6%
Return on sales
-385%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

AWH stock price

How has the Aspira Women's Health stock price performed over time
Intraday
-1.8%
1 week
-0.17%
1 month
-19.05%
1 year
386.99%
YTD
-10.73%
QTD
-11.26%

Financial performance

How have Aspira Women's Health's revenue and profit performed over time
Revenue
$4.65M
Gross profit
$1.24M
Operating income
-$17.98M
Net income
-$17.91M
Gross margin
26.6%
Net margin
-385%
The company's gross margin fell by 21% QoQ
AWH's gross profit is down by 19% since the previous quarter but it is up by 3.4% year-on-year
The net income has declined by 18% since the previous quarter and by 18% year-on-year
The operating income has declined by 18% year-on-year and by 17% since the previous quarter

Growth

What is Aspira Women's Health's growth rate over time

Valuation

What is Aspira Women's Health stock price valuation
P/E
N/A
P/B
64.15
P/S
129.72
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
141.4
The EPS has contracted by 13% from the previous quarter
The stock's P/B is 63% above its last 4 quarters average of 40.1
The company's equity fell by 33% QoQ but it rose by 11% YoY
AWH's price to sales (P/S) is 68% more than its last 4 quarters average of 78.7
Aspira Women's Health's revenue has increased by 3.1% from the previous quarter and by 2.5% YoY

Efficiency

How efficient is Aspira Women's Health business performance
The ROE has decreased by 20% YoY and by 15% from the previous quarter
The ROS has contracted by 15% YoY and by 14% from the previous quarter
The ROA has contracted by 7% from the previous quarter and by 3.7% YoY

Dividends

What is AWH's dividend history
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
Recent dividends

Financial health

How did Aspira Women's Health financials performed over time
Aspira Women's Health's total assets is 98% more than its total liabilities
Aspira Women's Health's total liabilities has soared by 94% YoY and by 47% from the previous quarter
Aspira Women's Health's total assets has increased by 42% YoY but it has decreased by 8% from the previous quarter
The debt is 47% smaller than the equity
Aspira Women's Health's debt to equity has soared by 194% from the previous quarter and by 179% YoY
The debt has surged by 98% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.